This brand name is authorized in Austria, Australia, Brazil, Cyprus, Spain, Finland, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Netherlands, Poland, Tunisia, United Kingdom, United States
The drug GLUCAGEN contains one active pharmaceutical ingredient (API):
1
Glucagon hydrochloride recombinant
UNII 1H87NVF4DB - GLUCAGON HYDROCHLORIDE
|
Glucagon is a hyperglycaemic agent that mobilises hepatic glycogen, which is released into the blood as glucose. Glucagon inhibits the tone and motility of the smooth muscle in the gastrointestinal tract. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
GLUCAGEN Powder and solvent for solution for injection | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
H04AA01 | Glucagon | H Systemic hormonal preparations, excl. Sex hormones and insulins → H04 Pancreatic hormones → H04A Glycogenolytic hormones → H04AA Glycogenolytic hormones |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: AU | Pharmaceutical Benefits Scheme | Identifier(s): 1449G, 3467L, 5105Q |
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 526600201150415 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 59327 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 443135, 443325 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 33996 |
Country: HK | Department of Health Drug Office | Identifier(s): 41845 |
Country: HR | Agencija za lijekove i medicinske proizvode | Identifier(s): HR-H-628981009 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 27027, 53492 |
Country: IL | מִשְׂרַד הַבְּרִיאוּת | Identifier(s): 642 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1004287 |
Country: MT | Medicines Authority | Identifier(s): MA104/00401, MA104/00402 |
Country: NL | Z-Index G-Standaard | Identifier(s): 13675109, 13675117 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 35327, 35335 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100205590 |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 5993031, 5993033 |
Country: US | FDA, National Drug Code | Identifier(s): 0597-0053 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.